PlainRecalls
FDA Drug Low Class III Terminated

Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08

Reported: August 29, 2018 Initiated: August 14, 2018 #D-1112-2018

Product Description

Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08

Reason for Recall

Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer

Details

Units Affected
408 cartons
Distribution
Nationwide USA
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08. Recalled by Mylan Institutional, Inc. (d.b.a. UDL Laboratories). Units affected: 408 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer
Which agency issued this recall?
This recall was issued by the FDA Drug on August 29, 2018. Severity: Low. Recall number: D-1112-2018.